News & Insights
July 26, 2021 FDA Issues New Draft Guidance for Sponsors on Safety Event Analysis and Reporting for IND and Bioavailability/Bioequivalence Studies
August 17, 2020 Federal Government Takes Steps Toward Enforcement of ClinicalTrials.gov Requirements
March 3, 2020 U.S. District Court Overturns HHS Interpretation of Final Rule that Permitted Sponsors of Certain Drug and Device Trials to Avoid Disclosure of Results on ClinicalTrials.gov